Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma
Article first published online: 24 MAY 2014
© 2014 John Wiley & Sons Ltd
Clinical & Experimental Allergy
Volume 44, Issue 6, pages 831–841, June 2014
How to Cite
Clinical & Experimental Allergy, 2014 (44) 831–841., , , and ,
Key points: This study shows an impaired ICOSL expression by human myeloid dendritic cells, which contributes to biased Th2 polarization in allergic rhinitis.
- Issue published online: 24 MAY 2014
- Article first published online: 24 MAY 2014
- Accepted manuscript online: 24 MAR 2014 05:22PM EST
- Manuscript Accepted: 27 FEB 2014
- Manuscript Revised: 25 FEB 2014
- Manuscript Received: 15 OCT 2013
- FRSM. Grant Numbers: 3.4512.12, 3.4.565.06–3.4522.12
- National de la Recherche Scientifique
- GSK research grant
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.